4//SEC Filing
Aegerion Pharmaceuticals, Inc. 4
Accession 0000899243-16-024278
CIK 0001338042operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:01 PM ET
Size
5.9 KB
Accession
0000899243-16-024278
Insider Transaction Report
Form 4
Chan Barbara Y
See Remarks
Transactions
- Award
Stock Option (right to buy)
2016-07-01+26,000→ 26,000 totalExercise: $1.58Exp: 2026-07-01→ Common Stock (26,000 underlying)
Footnotes (2)
- [F1]The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant.
- [F2]25% of the shares of common stock underlying this stock option award will vest on July 1, 2017. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through July 1, 2020, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338042
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:01 PM ET
- Size
- 5.9 KB